OCT 22, 2020 3:35 PM CEST

Next Generation rEvolution in Myeloid Neoplasms clinical research

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Myeloid neoplasms are a group of heterogeneus disorders originating from the neoplastic transformation of a pluripotent hematopoietic progenitor cell. Following the acquisition of somatic mutations there is an abnormal proliferation of hematopoietic cells from one or more cell lineages with the predominance of the neoplastic clone over the normal cells. Myeloid disorders are characterized by a high molecular complexity and by the presence of subclonal mutations occurring in subclones of variable size. The “classic” molecular biology techniques present several limits in terms of sensibility, sensitivity and time consuming. Next generation sequencing (NGS) have become fundamental for the in-depth study of molecular complexity and translational research in these diseases. Moreover the access to semi-automated platform and dedicated myeloid gene panels, represent an efficient and reliable opportunity for researchers to improve the quality of molecular data analysis.

Learning Objectives:

1. Evolution of technology in molecular biology

2. Next generation utility in myeloid neoplasm

3. Impact of NGS on translational research


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources